Product status
Investigational compound — not an approved consumer treatment. This listing does not represent an approved therapeutic indication.
Investigational triple-agonist research
Triple Agonist RT
Investigational status, stated without ambiguity.
Triple Agonist RT is an investigational triple-agonist compound studied for simultaneous activity at the GLP-1, GIP, and glucagon receptors. This mechanism is being evaluated in controlled clinical research involving weight management, glycemic measures, energy expenditure, and metabolic regulation.
Research use only · Not for human consumptionCurrent price$100.00
In stock
Research vial
Quantity
Investigational research material. Not an approved consumer treatment and not for human consumption.1
Research context
Clear information before ordering.
Published and sponsor-reported clinical-trial findings for the developer’s investigational retatrutide compound have reported substantial body-weight reductions and improvements in glycemic measures among studied participants. Researchers have also examined appetite signaling, insulin sensitivity, fat mass, and body composition. Retatrutide remains investigational, and those findings do not establish that this AURA research material is equivalent to the compound used in clinical trials or guarantee its safety, effectiveness, weight-loss results, fat reduction, muscle preservation, body recomposition, glycemic control, or any individual outcome.
Product format
Research reference material. Verify the final label, net quantity, and batch identity before accepting the material.
Documentation
Request batch-specific identity, purity, and testing documentation from support when available.
Storage
Follow only the verified label and batch documentation. Contact support if product-specific storage information is not supplied.
Product questions
About Triple Agonist RT
Straight answers, responsible limits, and a direct path to support.
No. This listing is educational and research-focused and does not present the material as an approved treatment.